Not Medicare Enrolled

Dr. Stephen Chakmakjian, MD

Pediatrics · Waco, TX
Low-engagement
601 W STATE HIGHWAY 6, Waco, TX 76710
2543998364
In practice since 2005 (20 years)
NPI: 1770566333 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chakmakjian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chakmakjian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chakmakjian

Dr. Stephen Chakmakjian is a pediatrics in Waco, TX, with 20 years in practice.

Between the years covered by Open Payments, Dr. Chakmakjian received a total of $4,111 from 32 pharmaceutical and/or device companies across 252 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatrics. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chakmakjian is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice$ $4,111 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$4,111
Total received (2018-2024)
Avg $587/year across 7 years
Top 3% in TX for pediatrics
32
Companies
252
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,111 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$592
2023
$731
2022
$400
2021
$788
2020
$568
2019
$492
2018
$539

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Corium, LLC
$604
Ironshore Pharmaceuticals Inc.
$397
Adlon Therapeutics L.P.
$305
Tris Pharma Inc
$301
Supernus Pharmaceuticals, Inc.
$292
Neos Therapeutics, LP
$284
PFIZER INC.
$229
Shire North American Group Inc
$210
Vertical Pharmaceuticals, LLC
$166
Genentech USA, Inc.
$162
Takeda Pharmaceuticals U.S.A., Inc.
$148
Cranial Technologies, Inc
$140
Merck Sharp & Dohme LLC
$120
GlaxoSmithKline, LLC.
$96
Merck Sharp & Dohme Corporation
$87
SANOFI PASTEUR INC.
$81
Corium, Inc.
$70
ARBOR PHARMACEUTICALS, INC.
$63
IRONSHORE PHARMACEUTICALS INC.
$59
Seqirus USA Inc
$58
Krystal Biotech Inc
$27
Alexion Pharmaceuticals, Inc.
$24
Novartis Pharmaceuticals Corporation
$23
ARRAY BIOPHARMA INC
$23
AstraZeneca Pharmaceuticals LP
$22
BioMarin Pharmaceutical Inc.
$21
SOBI, INC
$20
Sanofi Pasteur Inc.
$17
Kowa Pharmaceuticals America, Inc.
$15
Celgene Corporation
$15
Lupin Inc.
$15
Sobi, Inc
$14
Top 3 companies account for 31.8% of total payments
Associated products mentioned in payments ›
ADHANSIA XR · AZSTARYS · Adzenys XR-ODT · Azstarys · BEXSERO · BEYFORTUS · BRAFTOVI · CIPRODEX · COMIRNATY · COTEMPLA XR-ODT · Cotempla XR-ODT · Doc Band · Dyanavel XR · EUCRISA · Evekeo · FLUMIST QUADRIVALENT · FLUZONE QUADRIVALENT · Flucelvax · GARDASIL · GARDASIL 9 · GARDASIL9 · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · KOSELUGO · M-M-R II · MENACTRA · METHYLPHENIDATE 72 · OSMOLEX ER · Otovel · PREVNAR 13 · QELBREE · QUILLIVANT XR · Qelbree · Quillichew ER · Quillivant XR · REBLOZYL · RELEXXII · ROTATEQ · SUPRAX · SYNAGIS · TRUMENBA · VAXELIS · VOXZOGO 1.2mg · VYJUVEK · VYVANSE · Xofluza · ZORYVE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for pediatrics in TX.

Looking for a pediatrics in Waco?
Compare pediatricss in the Waco area by procedure volume, costs, and industry payment transparency.
Browse pediatricss nearby

Geographic Context

Pediatricss within 10 mi
33
Per 100K population
12.5
County median income
$63,888
Nearest hospital
ASCENSION PROVIDENCE
4.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Chakmakjian is a pediatrics, and high industry engagement (low-engagement, top 3%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Chakmakjian receive payments from pharmaceutical companies?
Yes. Dr. Chakmakjian received a total of $4,111 from 32 companies across 252 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Chakmakjian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Pediatricss in Waco
Browse pediatricss in Waco ranked by procedure volume and transparency data.
Highest volume
Top Pediatricss in TX
Pediatricss ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pediatricss in TX
Which TX pediatricss receive the most from drug and device companies.
By company
Corium, LLC Payments to Doctors
See all physicians who received payments from Corium, LLC.
By company
Ironshore Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Ironshore Pharmaceuticals Inc..
By company
Adlon Therapeutics L.P. Payments to Doctors
See all physicians who received payments from Adlon Therapeutics L.P..
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →